2022-04-11-世界卫生组织-Independent_Allocation_of_Vaccines_Group_IAVG_-_Terms_of_Reference_-_Phase_1_6页_77kb

Independent Allocation of Vaccines Group (IAVG) Summary

Purpose

The IAVG, established by WHO under the COVAX framework, validates VAD proposals submitted by the Joint Allocation Taskforce to ensure independent and transparent vaccine allocation, fostering ethical standards and critical assessment.

Key Functions

• Reviews VAD proposals for technical validity and data alignment.
• Requests clarifications and discusses adjustments with the JAT.
• Validates proposals by consensus, documenting all changes and justifications.
• Delivers final VAD proposals to the WHO Deputy-Director General for implementation.

Composition and Selection

• Composed of 12 expert members with diverse skills in global health, emergency response, and medical access, selected jointly by Gavi, CEPI, and WHO through open nomination.
• Members serve one-year renewable terms, emphasizing gender, geographical, and expertise balance, with a focus on avoiding conflicts of interest.

Operation and Meetings

• Meets bi-weekly by default, with virtual or in-person formats; decisions are reached by consensus.
• Quorum requires at least eight members; external observers may attend open sessions but cannot participate in validation assessments.
• WHO provides support services, including meeting documents, and maintains strict confidentiality requirements.

Additional Details

• The IAVG operates without remuneration but with travel costs covered for meetings.
• High confidentiality standards protect proprietary information, governed by WHO's rules and Terms of Reference to ensure independence and integrity.